1. Home
  2. CREG vs MEIP Comparison

CREG vs MEIP Comparison

Compare CREG & MEIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CREG
  • MEIP
  • Stock Information
  • Founded
  • CREG N/A
  • MEIP 2000
  • Country
  • CREG China
  • MEIP United States
  • Employees
  • CREG N/A
  • MEIP N/A
  • Industry
  • CREG Power Generation
  • MEIP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CREG Utilities
  • MEIP Health Care
  • Exchange
  • CREG Nasdaq
  • MEIP Nasdaq
  • Market Cap
  • CREG 16.6M
  • MEIP 13.3M
  • IPO Year
  • CREG N/A
  • MEIP 2003
  • Fundamental
  • Price
  • CREG $0.22
  • MEIP $2.80
  • Analyst Decision
  • CREG
  • MEIP Hold
  • Analyst Count
  • CREG 0
  • MEIP 1
  • Target Price
  • CREG N/A
  • MEIP N/A
  • AVG Volume (30 Days)
  • CREG 4.6M
  • MEIP 13.3K
  • Earning Date
  • CREG 08-13-2025
  • MEIP 05-13-2025
  • Dividend Yield
  • CREG N/A
  • MEIP N/A
  • EPS Growth
  • CREG N/A
  • MEIP N/A
  • EPS
  • CREG N/A
  • MEIP N/A
  • Revenue
  • CREG $20,625.00
  • MEIP N/A
  • Revenue This Year
  • CREG N/A
  • MEIP N/A
  • Revenue Next Year
  • CREG N/A
  • MEIP N/A
  • P/E Ratio
  • CREG N/A
  • MEIP N/A
  • Revenue Growth
  • CREG N/A
  • MEIP 33.76
  • 52 Week Low
  • CREG $0.20
  • MEIP $1.46
  • 52 Week High
  • CREG $1.47
  • MEIP $4.10
  • Technical
  • Relative Strength Index (RSI)
  • CREG 23.89
  • MEIP 78.43
  • Support Level
  • CREG $0.20
  • MEIP $2.21
  • Resistance Level
  • CREG $1.47
  • MEIP $2.95
  • Average True Range (ATR)
  • CREG 0.13
  • MEIP 0.15
  • MACD
  • CREG -0.03
  • MEIP 0.05
  • Stochastic Oscillator
  • CREG 1.77
  • MEIP 81.48

About CREG Smart Powerr Corp.

Smart Powerr Corp is a pioneer in waste energy recycling and a developer of energy efficiency solutions for various energy-intensive industries in China. It uses the Build-Operate-Transfer (BOT) model to provide energy-saving and recovery facilities for multiple energy-intensive industries in China. Its waste energy recycling projects allow customers which use substantial amounts of electricity to recapture previously wasted pressure, heat, and gas from their manufacturing processes to generate electricity. The company offers waste energy recycling systems to companies for use in nonferrous metal plants. It constructs its projects at its customer's facility and the electricity produced is used on-site by the customer.

About MEIP MEI Pharma Inc.

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

Share on Social Networks: